Ebola Transmission

This student page has not been curated.

Introduction

Workers from the Center for Disease Control (CDC) demonstrating proper attire worn in BSL-4 labs.

Double brackets: [[
Filename: [[1]]
Thumbnail status: |thumb|
Pixel size: |300px|
Placement on page: |right|
Legend/credit:
Closed double brackets: ]]

Other examples:
Bold
Italic
Subscript: H₂O
Superscript: Fe³⁺

The Ebola virus is Ebola is considered a Biosafety level 4 (BSL-4)agent. This indicates that it is among the most threatening agents that exist in the world today. Agents within this category pose sever threats to human health and can be fatal due to the lack of treatments and vaccines available.

Ebola Virus Structure

Include some current research in each topic, with at least one figure showing data.

Ebola Transmission

Include some current research in each topic, with at least one figure showing data.

Ebola Treatments

Include some current research in each topic, with at least one figure showing data.

Conclusion

Overall paper length should be 3,000 words, with at least 3 figures.

References

Phoolcharoen, Waranyoo, John M. Dye, et al. "A nonreplicating subunit vaccine protects mice against lethal Ebola virus challenge". Proceedings of the National Academy of Sciences of the United States of America. 2011. Volume 180.51. p. 20695-0700.

Weingartl, Hana M., Carissa Embury-Hyatt, Charles Nfon, Anders Leung, Greg Smith, and gary Kobinger. "Transmission of Ebola virus from pigs to non-human primates". Scientific Reports 2. 2012.

Edited by (Victoria Rose Gawlik), a student of Nora Sullivan in BIOL187S (Microbial Life) in The Keck Science Department of the Claremont Colleges Spring 2013.